Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Bang, Y.; Kwak, E. L.; Shaw, A. T.; Camidge, D. R.; Iafrate, A. J.; Maki, R. G.; Solomon, B. J.; Ou, S. I.; Salgia, R.; Clark, J. W. |
| Abstract Title: | Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC) |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-06-20 |
| Start Page: | 946s |
| Language: | English |
| ACCESSION: | WOS:000208880800003 |
| DOI: | 10.1200/jco.2010.28.18_suppl.3 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3 -- Source: Wos |
